Related Experiment Videos
Recurrent endometrial cancer: a retrospective study.
F H van Wijk1, F J Huikeshoven, L Abdulkadir
1Department of Obstetrics and Gynecological Diseases, Erasmus Medical Centre, Rotterdam, The Netherlands.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|February 8, 2006
Summary
Regular follow-up programs are valuable for detecting recurrent endometrial cancer within three years. Screen-detected recurrences show better survival rates, highlighting the importance of vigilant monitoring post-treatment.
Area of Science:
- Gynecologic Oncology
- Clinical Oncology
- Cancer Recurrence Monitoring
Background:
- Endometrial cancer recurrence poses a significant challenge in patient management.
- Effective follow-up strategies are crucial for early detection and improved outcomes.
Purpose of the Study:
- To evaluate the utility of follow-up programs in detecting endometrial cancer recurrence.
- To analyze the impact of detection methods on patient survival.
Main Methods:
- Retrospective analysis of 64 patients with recurrent endometrial cancer over 20 years.
- Evaluation of clinical data, histopathological features, and mode of recurrence detection.
- Survival analysis using Kaplan-Meier curves.
Main Results:
- Most local (95%) and distant (67%) recurrences were detected within three years.
- Screen-detected recurrences were associated with a higher 5-year survival rate (62%) compared to interval screening or chance findings (47%).
- Overall 5-year survival rate was 53%.
Conclusions:
- A follow-up program in the first three years post-treatment is beneficial for endometrial cancer recurrence detection.
- Current follow-up protocols appear suitable for patients with low-risk primary disease.